Who Generates Higher Gross Profit? Bio-Techne Corporation or Alkermes plc

Bio-Techne vs. Alkermes: A Decade of Profit Growth

__timestampAlkermes plcBio-Techne Corporation
Wednesday, January 1, 2014170914000251411000
Thursday, January 1, 2015144942000307277000
Friday, January 1, 2016226424000336659000
Sunday, January 1, 2017335737000374541000
Monday, January 1, 2018492448000432143000
Tuesday, January 1, 2019477729000473491000
Wednesday, January 1, 2020465852000483194000
Friday, January 1, 2021569838000632850000
Saturday, January 1, 2022893687000756496000
Sunday, January 1, 20231410368000769815000
Monday, January 1, 20241312301000769725000
Loading chart...

Unveiling the hidden dimensions of data

A Tale of Two Companies: Bio-Techne vs. Alkermes

In the competitive landscape of biotechnology, two companies have emerged as significant players: Bio-Techne Corporation and Alkermes plc. Over the past decade, these companies have demonstrated remarkable growth in gross profit, a key indicator of financial health and operational efficiency.

From 2014 to 2023, Alkermes plc has shown a staggering increase in gross profit, culminating in a 2023 figure that is nearly 8 times its 2014 value. This growth trajectory highlights Alkermes' strategic advancements and market adaptability. In contrast, Bio-Techne Corporation has maintained a steady upward trend, with its gross profit nearly tripling over the same period.

Interestingly, while Bio-Techne led in gross profit until 2021, Alkermes surged ahead in 2022 and 2023, showcasing a dynamic shift in market leadership. This data underscores the volatile yet exciting nature of the biotech industry, where innovation and strategy drive success.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025